Artículos por temáticas

A Network Pharmacology-Based Study of the Molecular Mechanisms of Shaoyao-Gancao Decoction in Treating Parkinson's Disease

Li L, Qiu H, Liu M, Cai Y.

Interdiscip Sci. 2020 Jun;12(2):131-144. doi: 10.1007/s12539-020-00359-7. Epub 2020 Jan 31.

Fibroblast mitochondria in idiopathic Parkinson's disease display morphological changes and enhanced resistance to depolarization

Antony PMA, Kondratyeva O, Mommaerts K, Ostaszewski M, Sokolowska K, Baumuratov AS, Longhino L, Poulain JF, Grossmann D, Balling R, Krüger R, Diederich NJ.

Sci Rep. 2020 Jan 31;10(1):1569. doi: 10.1038/s41598-020-58505-6.

Amyloid aggregates of the deubiquitinase OTUB1 are neurotoxic, suggesting that they contribute to the development of Parkinson's disease

Kumari R, Kumar R, Kumar S, Singh AK, Hanpude P, Jangir D, Maiti TK.

J Biol Chem. 2020 Mar 13;295(11):3466-3484. doi: 10.1074/jbc.RA119.009546. Epub 2020 Jan 31.

Protocol of a randomized open label multicentre trial comparing continuous intrajejunal levodopa infusion with deep brain stimulation in Parkinson's disease - the INfusion VErsus STimulation (INVEST) study

van Poppelen D, Sisodia V, de Haan RJ, Dijkgraaf MGW, Schuurman PR, Geurtsen GJ, Berk AEM, de Bie RMA, Dijk JM.

BMC Neurol. 2020 Jan 31;20(1):40. doi: 10.1186/s12883-020-1621-y.

Liposomes: Novel Drug Delivery Approach for Targeting Parkinson's Disease

Kumar B, Pandey M, Pottoo FH, Fayaz F, Sharma A, Sahoo PK.

Curr Pharm Des. 2020 Jan 28. doi: 10.2174/1381612826666200128145124. Online ahead of print.

In search of Parkinson's disease biomarkers - is the answer in our mouths? A systematic review of the literature on salivary biomarkers of Parkinson's disease

Figura M, Friedman A.

Neurol Neurochir Pol. 2020;54(1):14-20. doi: 10.5603/PJNNS.a2020.0011. Epub 2020 Jan 31.

Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological study

Smith CR, Cullen B, Sheridan MP, Cavanagh J, Grosset KA, Grosset DG.

Acta Neurol Scand. 2020 Jun;141(6):500-508. doi: 10.1111/ane.13226. Epub 2020 Feb 27.

Effects of Home-Based Working Memory Training on Visuo-Spatial Working Memory in Parkinson's Disease: A Randomized Controlled Trial

Giehl K, Ophey A, Reker P, Rehberg S, Hammes J, Barbe MT, Zokaei N, Eggers C, Husain M, Kalbe E, van Eimeren T.

J Cent Nerv Syst Dis. 2020 Jan 16;12:1179573519899469. doi: 10.1177/1179573519899469. eCollection 2020.

Cell-free microRNAs in Parkinson's disease: potential biomarkers that provide new insights into disease pathogenesis

Doxakis E.

Ageing Res Rev. 2020 Mar;58:101023. doi: 10.1016/j.arr.2020.101023. Epub 2020 Jan 27.

Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum

Chitre NM, Wood BJ, Ray A, Moniri NH, Murnane KS.

Neuropharmacology. 2020 May 1;167:107976. doi: 10.1016/j.neuropharm.2020.107976. Epub 2020 Jan 27.

A neurally plausible schema-theoretic approach to modelling cognitive dysfunction and neurophysiological markers in Parkinson's disease

Caso A, Cooper RP.

Neuropsychologia. 2020 Mar 16;140:107359. doi: 10.1016/j.neuropsychologia.2020.107359. Epub 2020 Jan 28.

The potential neuromodulatory impact of subthalamic nucleus deep brain stimulation on Parkinson's disease progression

Szlufik S, Duszynska-Lysak K, Przybyszewski A, Laskowska-Levy I, Drzewinska A, Dutkiewicz J, Mandat T, Habela P, Koziorowski D.

J Clin Neurosci. 2020 Mar;73:150-154. doi: 10.1016/j.jocn.2019.12.059. Epub 2020 Jan 27.

β-adrenoreceptors and the risk of Parkinson's disease

Hopfner F, Höglinger GU, Kuhlenbäumer G, Pottegård A, Wod M, Christensen K, Tanner CM, Deuschl G.

Lancet Neurol. 2020 Mar;19(3):247-254. doi: 10.1016/S1474-4422(19)30400-4. Epub 2020 Jan 27.

Behavioral and Neuroanatomical Account of Impulsivity in Parkinson's Disease

Hlavatá P, Linhartová P, Šumec R, Filip P, Světlák M, Baláž M, Kašpárek T, Bareš M.

Front Neurol. 2020 Jan 10;10:1338. doi: 10.3389/fneur.2019.01338. eCollection 2019.

Emerging Role of Sirtuin 2 in Parkinson's Disease

Liu Y, Zhang Y, Zhu K, Chi S, Wang C, Xie A.

Front Aging Neurosci. 2020 Jan 10;11:372. doi: 10.3389/fnagi.2019.00372. eCollection 2019.